Blood test may predict prostate cancer treatment success
NCT ID NCT03408964
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether certain substances in the blood can help doctors predict how prostate cancer patients will respond to their treatment. Researchers will collect blood samples from 600 men at different stages of prostate cancer and analyze them for biomarkers. The goal is to find better ways to personalize therapy and improve outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Oncology Institute of Southern Switzerland (IOSI)
RECRUITINGBellinzona, 6500, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can surgery boost control of spread prostate cancer?
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks